180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents
Oct 16, 2020
- The company’s patent portfolio includes its own intellectual property and exclusive worldwide licenses, including in the U.S., Canada, Europe, Australia, Hong Kong, and China
- 180 Life Sciences is in the final stages of its merger process with KBL Merger Corp. IV, with the resulting entity to list on NASDAQ under the ticker “ATNF”
- The company is devoting its clinical-stage biotechnology research to producing solutions that will help battle inflammation. Its primary focus is to treat fibrosis and inflammation using anti-TNF therapy
- The estimated annual market size for anti-inflammatory therapeutics is projected to grow to an estimated $106.1 billion in 2020.
KBL Merger Corp. IV (NASDAQ: KBLM), a special purpose acquisition corporation (“SPAC”) that has signed a detailed merger agreement with 180 Life Sciences Corp., announced that the company has continued to expand its IP portfolio. 180 Life Sciences Corp. is a clinical-stage biotech company currently in the developmental stage of three novel drugs. These drugs will fulfill the unmet need within the healthcare industry for inflammatory diseases, pain, and fibrosis.
The current patent portfolio that 180 Life Sciences Corp. has applied and received licenses for covers 14 patent families consisting of 42 patents issued and 32 pending in jurisdictions such as the United States, Europe, Canada, Japan, Australia, and…
NOTE TO INVESTORS: The latest news and updates relating to 180 Life Sciences are available in the company’s newsroom at http://ibn.fm/180
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.
More News
Trump and Xi Meet Amid an Uneasy U.S.-China Trade Truce
Beyond warm meetings between their leaders, the countries are engaging in tit-for-tat measures that call into question the stability of their arrangement.
Young Consultants Are Jumping Ship for A.I. Start-Ups
Beckoned by the glamour of the start-up space, the industry’s college recruits are joining A.I. companies able to outmatch their consulting salaries.
Bessent and China Hail Progress on A.I. Talks. Now Comes the Hard Part.
Artificial intelligence and more are expected to be big issues at this week’s summit between President Trump and Xi Jinping, China’s top leader.
Families missing out on NHS money for healthy food
Figures show as little as 64% of eligible families are claiming NHS money for milk, fruit and veg
U.S. and China Discuss System to Warn of A.I. National Security Issues
In a meeting on Sunday, the U.S. Treasury secretary and China’s vice premier talked about having a shared vision on the goals of artificial intelligence and the threats it poses.
Tories pledge to bring back tax-free shopping for tourists
The party says scrapping the scheme in 2021 left the UK less competitive than European destinations.
What are my rights if my flight is cancelled or delayed?
Flights are affected again owing to air traffic control problems, so what are your rights if you're affected?
Will you get £13,000 a year when you stop working? Here's how to check
How to find out how much state pension you're likely to receive - and what you can do about it now.
Nvidia boss rejects AI extinction fears as 'doomsday narratives'
Jensen Huang's comments come after warnings from AI researchers that the technology could lead to human extinction.
US and China discuss AI safety plan ahead of Trump-Xi summit
Top US and Chinese officials held talks in New York on Sunday ahead of a Trump-Xi summit this week.
Baby bank helping more parents in full-time work
The couple who run the bank say they are in "desperate need" of baby formula as demand is so high.
UK should 'team up' with Canada in new Europe alliance, Canadian minister tells BBC
It comes after European Commission President proposed "opening the door" for Canada to become an associate member of the EU.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.